Cargando…
Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways
Psoriasis, a chronic and immune-mediated inflammatory disease, adversely affects patients’ lives. We previously prepared selenium-rich yeast peptide fraction (SeP) from selenium-rich yeast protein hydrolysate and found that SeP could effectively alleviate ultraviolet radiation-induced skin damage in...
Autores principales: | Guo, Hengke, Li, Min, Liu, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875820/ https://www.ncbi.nlm.nih.gov/pubmed/35216231 http://dx.doi.org/10.3390/ijms23042112 |
Ejemplares similares
-
Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway
por: Liu, Aimin, et al.
Publicado: (2020) -
Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Lee, Seung Hoon, et al.
Publicado: (2022) -
P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
por: Chen, Haiming, et al.
Publicado: (2022) -
4'-O-β-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-κB and MAPK signaling pathways
por: Fu, Jing, et al.
Publicado: (2020) -
Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020)